nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—Lipase increased—Telbivudine—hepatitis B	0.0254	0.0313	CcSEcCtD
Bexarotene—Laboratory test abnormal—Entecavir—hepatitis B	0.0218	0.0268	CcSEcCtD
Bexarotene—Body odor—Lamivudine—hepatitis B	0.0193	0.0237	CcSEcCtD
Bexarotene—Kidney function abnormal—Adefovir Dipivoxil—hepatitis B	0.0184	0.0226	CcSEcCtD
Bexarotene—Amylase increased—Telbivudine—hepatitis B	0.0157	0.0193	CcSEcCtD
Bexarotene—Skin odour abnormal—Lamivudine—hepatitis B	0.0143	0.0176	CcSEcCtD
Bexarotene—RXRA—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.0109	0.0578	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.0101	0.0535	CbGpPWpGaD
Bexarotene—Cough increased—Adefovir Dipivoxil—hepatitis B	0.00969	0.0119	CcSEcCtD
Bexarotene—RXRB—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.00946	0.0503	CbGpPWpGaD
Bexarotene—Creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00932	0.0115	CcSEcCtD
Bexarotene—Bone pain—Adefovir Dipivoxil—hepatitis B	0.00926	0.0114	CcSEcCtD
Bexarotene—Hepatocellular injury—Adefovir Dipivoxil—hepatitis B	0.00887	0.0109	CcSEcCtD
Bexarotene—Amylase increased—Lamivudine—hepatitis B	0.00884	0.0109	CcSEcCtD
Bexarotene—RXRG—Nuclear Receptors—HNF4A—hepatitis B	0.00883	0.047	CbGpPWpGaD
Bexarotene—Hyperkalaemia—Adefovir Dipivoxil—hepatitis B	0.00871	0.0107	CcSEcCtD
Bexarotene—RXRB—Nuclear Receptors—HNF4A—hepatitis B	0.0083	0.0441	CbGpPWpGaD
Bexarotene—Hepatic failure—Entecavir—hepatitis B	0.00734	0.00904	CcSEcCtD
Bexarotene—Hypertriglyceridaemia—Lamivudine—hepatitis B	0.00733	0.00902	CcSEcCtD
Bexarotene—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.00716	0.00882	CcSEcCtD
Bexarotene—RXRG—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.00698	0.0371	CbGpPWpGaD
Bexarotene—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.00676	0.00833	CcSEcCtD
Bexarotene—RXRB—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.00656	0.0349	CbGpPWpGaD
Bexarotene—Breast enlargement—Lamivudine—hepatitis B	0.00649	0.00799	CcSEcCtD
Bexarotene—Sepsis—Telbivudine—hepatitis B	0.00648	0.00798	CcSEcCtD
Bexarotene—Blood triglycerides increased—Lamivudine—hepatitis B	0.00642	0.00791	CcSEcCtD
Bexarotene—Bone marrow depression—Lamivudine—hepatitis B	0.00623	0.00768	CcSEcCtD
Bexarotene—Blood creatinine increased—Entecavir—hepatitis B	0.00618	0.00761	CcSEcCtD
Bexarotene—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00603	0.00743	CcSEcCtD
Bexarotene—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00594	0.00732	CcSEcCtD
Bexarotene—Renal impairment—Telbivudine—hepatitis B	0.0057	0.00702	CcSEcCtD
Bexarotene—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00568	0.00699	CcSEcCtD
Bexarotene—Pancreatitis—Entecavir—hepatitis B	0.00559	0.00689	CcSEcCtD
Bexarotene—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00546	0.00672	CcSEcCtD
Bexarotene—Hyperaesthesia—Lamivudine—hepatitis B	0.00536	0.0066	CcSEcCtD
Bexarotene—Migraine—Telbivudine—hepatitis B	0.00534	0.00657	CcSEcCtD
Bexarotene—Neutropenia—Entecavir—hepatitis B	0.00533	0.00657	CcSEcCtD
Bexarotene—Hyperglycaemia—Entecavir—hepatitis B	0.00514	0.00634	CcSEcCtD
Bexarotene—Blood disorder—Lamivudine—hepatitis B	0.00504	0.00621	CcSEcCtD
Bexarotene—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00503	0.0062	CcSEcCtD
Bexarotene—Acne—Lamivudine—hepatitis B	0.005	0.00616	CcSEcCtD
Bexarotene—RXRA—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.00493	0.0262	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—MIF—hepatitis B	0.00493	0.0262	CbGpPWpGaD
Bexarotene—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00488	0.00601	CcSEcCtD
Bexarotene—Haematuria—Entecavir—hepatitis B	0.00485	0.00597	CcSEcCtD
Bexarotene—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00484	0.00596	CcSEcCtD
Bexarotene—Muscular weakness—Telbivudine—hepatitis B	0.00478	0.00589	CcSEcCtD
Bexarotene—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00478	0.00589	CcSEcCtD
Bexarotene—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00473	0.00583	CcSEcCtD
Bexarotene—Abdominal distension—Telbivudine—hepatitis B	0.00472	0.00581	CcSEcCtD
Bexarotene—Influenza—Telbivudine—hepatitis B	0.00469	0.00577	CcSEcCtD
Bexarotene—RXRA—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00467	0.0248	CbGpPWpGaD
Bexarotene—Viral infection—Lamivudine—hepatitis B	0.00466	0.00574	CcSEcCtD
Bexarotene—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00465	0.00573	CcSEcCtD
Bexarotene—Oedema peripheral—Entecavir—hepatitis B	0.0045	0.00554	CcSEcCtD
Bexarotene—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00445	0.00548	CcSEcCtD
Bexarotene—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00442	0.00544	CcSEcCtD
Bexarotene—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.0044	0.00542	CcSEcCtD
Bexarotene—Neutropenia—Telbivudine—hepatitis B	0.00438	0.0054	CcSEcCtD
Bexarotene—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00438	0.00539	CcSEcCtD
Bexarotene—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00437	0.00538	CcSEcCtD
Bexarotene—RXRA—Nuclear Receptors—HNF4A—hepatitis B	0.00433	0.023	CbGpPWpGaD
Bexarotene—Eructation—Lamivudine—hepatitis B	0.00413	0.00509	CcSEcCtD
Bexarotene—Neuropathy peripheral—Telbivudine—hepatitis B	0.00409	0.00504	CcSEcCtD
Bexarotene—CYP2C9—CYP2E1 reactions—CYP2A6—hepatitis B	0.00409	0.0218	CbGpPWpGaD
Bexarotene—Alopecia—Entecavir—hepatitis B	0.00403	0.00497	CcSEcCtD
Bexarotene—Malnutrition—Entecavir—hepatitis B	0.00397	0.00489	CcSEcCtD
Bexarotene—Neuropathy—Lamivudine—hepatitis B	0.00395	0.00487	CcSEcCtD
Bexarotene—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00388	0.00478	CcSEcCtD
Bexarotene—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00382	0.00471	CcSEcCtD
Bexarotene—Mouth ulceration—Lamivudine—hepatitis B	0.00381	0.00469	CcSEcCtD
Bexarotene—Urine output increased—Lamivudine—hepatitis B	0.00381	0.00469	CcSEcCtD
Bexarotene—Back pain—Adefovir Dipivoxil—hepatitis B	0.00375	0.00462	CcSEcCtD
Bexarotene—Hypoaesthesia—Telbivudine—hepatitis B	0.00373	0.0046	CcSEcCtD
Bexarotene—Pharyngitis—Telbivudine—hepatitis B	0.00372	0.00458	CcSEcCtD
Bexarotene—Connective tissue disorder—Telbivudine—hepatitis B	0.00369	0.00454	CcSEcCtD
Bexarotene—Sepsis—Lamivudine—hepatitis B	0.00365	0.0045	CcSEcCtD
Bexarotene—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00358	0.00441	CcSEcCtD
Bexarotene—Lymphadenopathy—Lamivudine—hepatitis B	0.00358	0.00441	CcSEcCtD
Bexarotene—Leukopenia—Entecavir—hepatitis B	0.00356	0.00438	CcSEcCtD
Bexarotene—Polyuria—Lamivudine—hepatitis B	0.00348	0.00428	CcSEcCtD
Bexarotene—Gastroenteritis—Lamivudine—hepatitis B	0.00345	0.00425	CcSEcCtD
Bexarotene—RXRA—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.00342	0.0182	CbGpPWpGaD
Bexarotene—Deafness—Lamivudine—hepatitis B	0.00342	0.00421	CcSEcCtD
Bexarotene—Cough—Adefovir Dipivoxil—hepatitis B	0.00338	0.00417	CcSEcCtD
Bexarotene—RXRA—Recycling of bile acids and salts—ALB—hepatitis B	0.00337	0.0179	CbGpPWpGaD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00336	0.00414	CcSEcCtD
Bexarotene—Myalgia—Adefovir Dipivoxil—hepatitis B	0.0033	0.00407	CcSEcCtD
Bexarotene—Chest pain—Adefovir Dipivoxil—hepatitis B	0.0033	0.00407	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00328	0.00404	CcSEcCtD
Bexarotene—Malnutrition—Telbivudine—hepatitis B	0.00326	0.00402	CcSEcCtD
Bexarotene—Infection—Entecavir—hepatitis B	0.00322	0.00397	CcSEcCtD
Bexarotene—Renal impairment—Lamivudine—hepatitis B	0.00321	0.00395	CcSEcCtD
Bexarotene—Thirst—Lamivudine—hepatitis B	0.00321	0.00395	CcSEcCtD
Bexarotene—Dysgeusia—Telbivudine—hepatitis B	0.0032	0.00394	CcSEcCtD
Bexarotene—Nervous system disorder—Entecavir—hepatitis B	0.00318	0.00392	CcSEcCtD
Bexarotene—Back pain—Telbivudine—hepatitis B	0.00316	0.00389	CcSEcCtD
Bexarotene—Skin disorder—Entecavir—hepatitis B	0.00315	0.00388	CcSEcCtD
Bexarotene—Muscle spasms—Telbivudine—hepatitis B	0.00314	0.00387	CcSEcCtD
Bexarotene—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.0031	0.00382	CcSEcCtD
Bexarotene—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.0031	0.00382	CcSEcCtD
Bexarotene—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00307	0.00379	CcSEcCtD
Bexarotene—Ill-defined disorder—Telbivudine—hepatitis B	0.00303	0.00373	CcSEcCtD
Bexarotene—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00302	0.00371	CcSEcCtD
Bexarotene—Migraine—Lamivudine—hepatitis B	0.00301	0.0037	CcSEcCtD
Bexarotene—Affect lability—Lamivudine—hepatitis B	0.00301	0.0037	CcSEcCtD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—hepatitis B	0.00295	0.0157	CbGpPWpGaD
Bexarotene—Malaise—Telbivudine—hepatitis B	0.00294	0.00363	CcSEcCtD
Bexarotene—Insomnia—Entecavir—hepatitis B	0.00293	0.00361	CcSEcCtD
Bexarotene—Mood swings—Lamivudine—hepatitis B	0.00289	0.00356	CcSEcCtD
Bexarotene—Somnolence—Entecavir—hepatitis B	0.00288	0.00355	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00288	0.00355	CcSEcCtD
Bexarotene—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00288	0.0153	CbGpPWpGaD
Bexarotene—Dyspepsia—Entecavir—hepatitis B	0.00285	0.00352	CcSEcCtD
Bexarotene—Cough—Telbivudine—hepatitis B	0.00285	0.00351	CcSEcCtD
Bexarotene—Dehydration—Lamivudine—hepatitis B	0.00284	0.0035	CcSEcCtD
Bexarotene—RXRA—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00282	0.015	CbGpPWpGaD
Bexarotene—Liver function test abnormal—Lamivudine—hepatitis B	0.00282	0.00347	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Entecavir—hepatitis B	0.0028	0.00345	CcSEcCtD
Bexarotene—Fatigue—Entecavir—hepatitis B	0.0028	0.00344	CcSEcCtD
Bexarotene—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00279	0.00343	CcSEcCtD
Bexarotene—Myalgia—Telbivudine—hepatitis B	0.00278	0.00342	CcSEcCtD
Bexarotene—Chest pain—Telbivudine—hepatitis B	0.00278	0.00342	CcSEcCtD
Bexarotene—Arthralgia—Telbivudine—hepatitis B	0.00278	0.00342	CcSEcCtD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—hepatitis B	0.00278	0.0148	CbGpPWpGaD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00276	0.0034	CcSEcCtD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—hepatitis B	0.00276	0.0147	CbGpPWpGaD
Bexarotene—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00275	0.00339	CcSEcCtD
Bexarotene—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00275	0.00339	CcSEcCtD
Bexarotene—Discomfort—Telbivudine—hepatitis B	0.00275	0.00338	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00273	0.00336	CcSEcCtD
Bexarotene—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00269	0.00332	CcSEcCtD
Bexarotene—Muscular weakness—Lamivudine—hepatitis B	0.00269	0.00332	CcSEcCtD
Bexarotene—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.00268	0.0142	CbGpPWpGaD
Bexarotene—Abdominal distension—Lamivudine—hepatitis B	0.00266	0.00327	CcSEcCtD
Bexarotene—Gastrointestinal pain—Entecavir—hepatitis B	0.00265	0.00327	CcSEcCtD
Bexarotene—Influenza—Lamivudine—hepatitis B	0.00264	0.00325	CcSEcCtD
Bexarotene—Dysphagia—Lamivudine—hepatitis B	0.00264	0.00325	CcSEcCtD
Bexarotene—Nervous system disorder—Telbivudine—hepatitis B	0.00261	0.00322	CcSEcCtD
Bexarotene—Thrombocytopenia—Telbivudine—hepatitis B	0.00261	0.00321	CcSEcCtD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—hepatitis B	0.00259	0.0138	CbGpPWpGaD
Bexarotene—Pancreatitis—Lamivudine—hepatitis B	0.00259	0.00319	CcSEcCtD
Bexarotene—Skin disorder—Telbivudine—hepatitis B	0.00259	0.00319	CcSEcCtD
Bexarotene—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00259	0.00319	CcSEcCtD
Bexarotene—Body temperature increased—Entecavir—hepatitis B	0.00256	0.00316	CcSEcCtD
Bexarotene—Abdominal pain—Entecavir—hepatitis B	0.00256	0.00316	CcSEcCtD
Bexarotene—Bronchitis—Lamivudine—hepatitis B	0.00254	0.00313	CcSEcCtD
Bexarotene—CYP2C9—Xenobiotics—CYP2A6—hepatitis B	0.00254	0.0135	CbGpPWpGaD
Bexarotene—Pancytopenia—Lamivudine—hepatitis B	0.00251	0.00309	CcSEcCtD
Bexarotene—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.0025	0.00308	CcSEcCtD
Bexarotene—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.0025	0.00308	CcSEcCtD
Bexarotene—Dysuria—Lamivudine—hepatitis B	0.00247	0.00304	CcSEcCtD
Bexarotene—Neutropenia—Lamivudine—hepatitis B	0.00247	0.00304	CcSEcCtD
Bexarotene—CYP2C9—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00244	0.013	CbGpPWpGaD
Bexarotene—Pollakiuria—Lamivudine—hepatitis B	0.00244	0.003	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00243	0.00299	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—MIF—hepatitis B	0.00242	0.0128	CbGpPWpGaD
Bexarotene—Insomnia—Telbivudine—hepatitis B	0.00241	0.00297	CcSEcCtD
Bexarotene—Paraesthesia—Telbivudine—hepatitis B	0.00239	0.00295	CcSEcCtD
Bexarotene—Hyperglycaemia—Lamivudine—hepatitis B	0.00238	0.00293	CcSEcCtD
Bexarotene—Dyspepsia—Telbivudine—hepatitis B	0.00235	0.00289	CcSEcCtD
Bexarotene—Asthenia—Entecavir—hepatitis B	0.00233	0.00287	CcSEcCtD
Bexarotene—Neuropathy peripheral—Lamivudine—hepatitis B	0.00231	0.00284	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Telbivudine—hepatitis B	0.0023	0.00283	CcSEcCtD
Bexarotene—Fatigue—Telbivudine—hepatitis B	0.0023	0.00283	CcSEcCtD
Bexarotene—Stomatitis—Lamivudine—hepatitis B	0.00229	0.00283	CcSEcCtD
Bexarotene—Jaundice—Lamivudine—hepatitis B	0.00229	0.00283	CcSEcCtD
Bexarotene—RXRA—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00229	0.0122	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—GGT2—hepatitis B	0.00229	0.0122	CbGpPWpGaD
Bexarotene—Pain—Telbivudine—hepatitis B	0.00228	0.00281	CcSEcCtD
Bexarotene—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00227	0.0028	CcSEcCtD
Bexarotene—Sweating—Lamivudine—hepatitis B	0.00226	0.00278	CcSEcCtD
Bexarotene—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00224	0.00276	CcSEcCtD
Bexarotene—Epistaxis—Lamivudine—hepatitis B	0.00222	0.00273	CcSEcCtD
Bexarotene—Diarrhoea—Entecavir—hepatitis B	0.00222	0.00273	CcSEcCtD
Bexarotene—Sinusitis—Lamivudine—hepatitis B	0.00221	0.00272	CcSEcCtD
Bexarotene—Feeling abnormal—Telbivudine—hepatitis B	0.0022	0.0027	CcSEcCtD
Bexarotene—Gastrointestinal pain—Telbivudine—hepatitis B	0.00218	0.00268	CcSEcCtD
Bexarotene—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00217	0.00267	CcSEcCtD
Bexarotene—Dizziness—Entecavir—hepatitis B	0.00214	0.00264	CcSEcCtD
Bexarotene—Rhinitis—Lamivudine—hepatitis B	0.00212	0.00261	CcSEcCtD
Bexarotene—Body temperature increased—Telbivudine—hepatitis B	0.00211	0.00259	CcSEcCtD
Bexarotene—Abdominal pain—Telbivudine—hepatitis B	0.00211	0.00259	CcSEcCtD
Bexarotene—Hypoaesthesia—Lamivudine—hepatitis B	0.0021	0.00259	CcSEcCtD
Bexarotene—Pharyngitis—Lamivudine—hepatitis B	0.0021	0.00258	CcSEcCtD
Bexarotene—Connective tissue disorder—Lamivudine—hepatitis B	0.00208	0.00256	CcSEcCtD
Bexarotene—Vomiting—Entecavir—hepatitis B	0.00206	0.00254	CcSEcCtD
Bexarotene—Rash—Entecavir—hepatitis B	0.00204	0.00252	CcSEcCtD
Bexarotene—Dermatitis—Entecavir—hepatitis B	0.00204	0.00252	CcSEcCtD
Bexarotene—Headache—Entecavir—hepatitis B	0.00203	0.0025	CcSEcCtD
Bexarotene—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00201	0.00248	CcSEcCtD
Bexarotene—RXRA—Biological oxidations—GGT2—hepatitis B	0.00201	0.0107	CbGpPWpGaD
Bexarotene—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.002	0.0106	CbGpPWpGaD
Bexarotene—Rash—Adefovir Dipivoxil—hepatitis B	0.002	0.00246	CcSEcCtD
Bexarotene—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00199	0.00246	CcSEcCtD
Bexarotene—Headache—Adefovir Dipivoxil—hepatitis B	0.00198	0.00244	CcSEcCtD
Bexarotene—Nausea—Entecavir—hepatitis B	0.00193	0.00237	CcSEcCtD
Bexarotene—Asthenia—Telbivudine—hepatitis B	0.00191	0.00235	CcSEcCtD
Bexarotene—Chills—Lamivudine—hepatitis B	0.0019	0.00234	CcSEcCtD
Bexarotene—Pruritus—Telbivudine—hepatitis B	0.00188	0.00232	CcSEcCtD
Bexarotene—Nausea—Adefovir Dipivoxil—hepatitis B	0.00188	0.00231	CcSEcCtD
Bexarotene—Alopecia—Lamivudine—hepatitis B	0.00187	0.0023	CcSEcCtD
Bexarotene—Erythema—Lamivudine—hepatitis B	0.00184	0.00227	CcSEcCtD
Bexarotene—Malnutrition—Lamivudine—hepatitis B	0.00184	0.00227	CcSEcCtD
Bexarotene—Diarrhoea—Telbivudine—hepatitis B	0.00182	0.00225	CcSEcCtD
Bexarotene—Flatulence—Lamivudine—hepatitis B	0.00181	0.00223	CcSEcCtD
Bexarotene—Tension—Lamivudine—hepatitis B	0.00181	0.00222	CcSEcCtD
Bexarotene—Dysgeusia—Lamivudine—hepatitis B	0.0018	0.00222	CcSEcCtD
Bexarotene—RXRG—Adipogenesis—FAS—hepatitis B	0.00179	0.00953	CbGpPWpGaD
Bexarotene—Nervousness—Lamivudine—hepatitis B	0.00179	0.0022	CcSEcCtD
Bexarotene—Back pain—Lamivudine—hepatitis B	0.00178	0.00219	CcSEcCtD
Bexarotene—Muscle spasms—Lamivudine—hepatitis B	0.00177	0.00218	CcSEcCtD
Bexarotene—RXRA—Bile acid and bile salt metabolism—ALB—hepatitis B	0.00176	0.00938	CbGpPWpGaD
Bexarotene—Dizziness—Telbivudine—hepatitis B	0.00176	0.00217	CcSEcCtD
Bexarotene—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00174	0.00927	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—NR0B2—hepatitis B	0.00174	0.00925	CbGpPWpGaD
Bexarotene—Ill-defined disorder—Lamivudine—hepatitis B	0.00171	0.0021	CcSEcCtD
Bexarotene—Anaemia—Lamivudine—hepatitis B	0.0017	0.00209	CcSEcCtD
Bexarotene—Vomiting—Telbivudine—hepatitis B	0.00169	0.00209	CcSEcCtD
Bexarotene—Rash—Telbivudine—hepatitis B	0.00168	0.00207	CcSEcCtD
Bexarotene—Dermatitis—Telbivudine—hepatitis B	0.00168	0.00207	CcSEcCtD
Bexarotene—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.00167	0.0089	CbGpPWpGaD
Bexarotene—Headache—Telbivudine—hepatitis B	0.00167	0.00206	CcSEcCtD
Bexarotene—Malaise—Lamivudine—hepatitis B	0.00166	0.00204	CcSEcCtD
Bexarotene—Vertigo—Lamivudine—hepatitis B	0.00165	0.00204	CcSEcCtD
Bexarotene—Syncope—Lamivudine—hepatitis B	0.00165	0.00203	CcSEcCtD
Bexarotene—Leukopenia—Lamivudine—hepatitis B	0.00165	0.00203	CcSEcCtD
Bexarotene—RXRB—Generic Transcription Pathway—NR0B2—hepatitis B	0.00163	0.00869	CbGpPWpGaD
Bexarotene—Loss of consciousness—Lamivudine—hepatitis B	0.00162	0.00199	CcSEcCtD
Bexarotene—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00161	0.00856	CbGpPWpGaD
Bexarotene—Cough—Lamivudine—hepatitis B	0.00161	0.00198	CcSEcCtD
Bexarotene—Nausea—Telbivudine—hepatitis B	0.00158	0.00195	CcSEcCtD
Bexarotene—Chest pain—Lamivudine—hepatitis B	0.00157	0.00193	CcSEcCtD
Bexarotene—Arthralgia—Lamivudine—hepatitis B	0.00157	0.00193	CcSEcCtD
Bexarotene—Myalgia—Lamivudine—hepatitis B	0.00157	0.00193	CcSEcCtD
Bexarotene—Anxiety—Lamivudine—hepatitis B	0.00156	0.00192	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00156	0.00192	CcSEcCtD
Bexarotene—Discomfort—Lamivudine—hepatitis B	0.00155	0.00191	CcSEcCtD
Bexarotene—RXRA—Transcription factor regulation in adipogenesis—TNF—hepatitis B	0.00154	0.00821	CbGpPWpGaD
Bexarotene—Dry mouth—Lamivudine—hepatitis B	0.00153	0.00189	CcSEcCtD
Bexarotene—Confusional state—Lamivudine—hepatitis B	0.00151	0.00186	CcSEcCtD
Bexarotene—Oedema—Lamivudine—hepatitis B	0.0015	0.00185	CcSEcCtD
Bexarotene—Infection—Lamivudine—hepatitis B	0.00149	0.00184	CcSEcCtD
Bexarotene—Shock—Lamivudine—hepatitis B	0.00148	0.00182	CcSEcCtD
Bexarotene—Nervous system disorder—Lamivudine—hepatitis B	0.00147	0.00181	CcSEcCtD
Bexarotene—Thrombocytopenia—Lamivudine—hepatitis B	0.00147	0.00181	CcSEcCtD
Bexarotene—Skin disorder—Lamivudine—hepatitis B	0.00146	0.0018	CcSEcCtD
Bexarotene—Hyperhidrosis—Lamivudine—hepatitis B	0.00145	0.00179	CcSEcCtD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—hepatitis B	0.00145	0.0077	CbGpPWpGaD
Bexarotene—Anorexia—Lamivudine—hepatitis B	0.00143	0.00176	CcSEcCtD
Bexarotene—RXRA—NRF2 pathway—CYP2A6—hepatitis B	0.00139	0.00737	CbGpPWpGaD
Bexarotene—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00137	0.00168	CcSEcCtD
Bexarotene—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00136	0.00724	CbGpPWpGaD
Bexarotene—Insomnia—Lamivudine—hepatitis B	0.00136	0.00167	CcSEcCtD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—hepatitis B	0.00135	0.00719	CbGpPWpGaD
Bexarotene—Paraesthesia—Lamivudine—hepatitis B	0.00135	0.00166	CcSEcCtD
Bexarotene—Dyspnoea—Lamivudine—hepatitis B	0.00134	0.00165	CcSEcCtD
Bexarotene—Somnolence—Lamivudine—hepatitis B	0.00133	0.00164	CcSEcCtD
Bexarotene—Dyspepsia—Lamivudine—hepatitis B	0.00132	0.00163	CcSEcCtD
Bexarotene—Decreased appetite—Lamivudine—hepatitis B	0.00131	0.00161	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Lamivudine—hepatitis B	0.0013	0.0016	CcSEcCtD
Bexarotene—Fatigue—Lamivudine—hepatitis B	0.00129	0.00159	CcSEcCtD
Bexarotene—Pain—Lamivudine—hepatitis B	0.00128	0.00158	CcSEcCtD
Bexarotene—Constipation—Lamivudine—hepatitis B	0.00128	0.00158	CcSEcCtD
Bexarotene—RXRA—Transcription factor regulation in adipogenesis—IL6—hepatitis B	0.00125	0.00663	CbGpPWpGaD
Bexarotene—Feeling abnormal—Lamivudine—hepatitis B	0.00124	0.00152	CcSEcCtD
Bexarotene—Gastrointestinal pain—Lamivudine—hepatitis B	0.00123	0.00151	CcSEcCtD
Bexarotene—RXRA—Biological oxidations—CYP2A6—hepatitis B	0.00122	0.00646	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—HNF4A—hepatitis B	0.00121	0.00641	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.00119	0.00632	CbGpPWpGaD
Bexarotene—Abdominal pain—Lamivudine—hepatitis B	0.00119	0.00146	CcSEcCtD
Bexarotene—Body temperature increased—Lamivudine—hepatitis B	0.00119	0.00146	CcSEcCtD
Bexarotene—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00115	0.00611	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—HNF4A—hepatitis B	0.00113	0.00603	CbGpPWpGaD
Bexarotene—Hypersensitivity—Lamivudine—hepatitis B	0.00111	0.00136	CcSEcCtD
Bexarotene—RXRA—NRF2 pathway—GGT1—hepatitis B	0.00108	0.00575	CbGpPWpGaD
Bexarotene—Asthenia—Lamivudine—hepatitis B	0.00108	0.00133	CcSEcCtD
Bexarotene—Pruritus—Lamivudine—hepatitis B	0.00106	0.00131	CcSEcCtD
Bexarotene—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00105	0.0056	CbGpPWpGaD
Bexarotene—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00104	0.00553	CbGpPWpGaD
Bexarotene—Diarrhoea—Lamivudine—hepatitis B	0.00103	0.00127	CcSEcCtD
Bexarotene—RXRG—Adipogenesis—CTNNB1—hepatitis B	0.00101	0.00536	CbGpPWpGaD
Bexarotene—Dizziness—Lamivudine—hepatitis B	0.000993	0.00122	CcSEcCtD
Bexarotene—RXRG—Adipogenesis—CDKN1A—hepatitis B	0.000985	0.00524	CbGpPWpGaD
Bexarotene—Vomiting—Lamivudine—hepatitis B	0.000955	0.00118	CcSEcCtD
Bexarotene—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	0.000952	0.00506	CbGpPWpGaD
Bexarotene—RXRA—Biological oxidations—GGT1—hepatitis B	0.000949	0.00505	CbGpPWpGaD
Bexarotene—Rash—Lamivudine—hepatitis B	0.000947	0.00117	CcSEcCtD
Bexarotene—Dermatitis—Lamivudine—hepatitis B	0.000946	0.00116	CcSEcCtD
Bexarotene—Headache—Lamivudine—hepatitis B	0.000941	0.00116	CcSEcCtD
Bexarotene—Nausea—Lamivudine—hepatitis B	0.000892	0.0011	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—FAS—hepatitis B	0.000878	0.00467	CbGpPWpGaD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000854	0.00454	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—NR0B2—hepatitis B	0.000852	0.00453	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—NR0B2—hepatitis B	0.000837	0.00445	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—TGFB1—hepatitis B	0.000815	0.00433	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000804	0.00427	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—NR0B2—hepatitis B	0.000787	0.00419	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.000771	0.0041	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—TNF—hepatitis B	0.000761	0.00405	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.000749	0.00398	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—NFKB1—hepatitis B	0.000729	0.00388	CbGpPWpGaD
Bexarotene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000695	0.0037	CbGpPWpGaD
Bexarotene—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000686	0.00365	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.00067	0.00356	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000646	0.00343	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—IL6—hepatitis B	0.000614	0.00327	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—hepatitis B	0.000607	0.00323	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—HNF4A—hepatitis B	0.000591	0.00314	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—HNF4A—hepatitis B	0.00058	0.00309	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—hepatitis B	0.000567	0.00302	CbGpPWpGaD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000563	0.003	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—HNF4A—hepatitis B	0.000556	0.00296	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—HNF4A—hepatitis B	0.000546	0.0029	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000508	0.0027	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—CTNNB1—hepatitis B	0.000494	0.00263	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000494	0.00263	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—CDKN1A—hepatitis B	0.000483	0.00257	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	0.000454	0.00241	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—NR0B2—hepatitis B	0.00041	0.00218	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—TGFB1—hepatitis B	0.000399	0.00212	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—TNF—hepatitis B	0.000373	0.00198	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000364	0.00194	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—TGFB1—hepatitis B	0.000364	0.00194	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000363	0.00193	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—AKR1B1—hepatitis B	0.000358	0.0019	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000355	0.00189	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—GGT1—hepatitis B	0.000354	0.00188	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000354	0.00188	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000352	0.00187	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GGT2—hepatitis B	0.000343	0.00182	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—IL6—hepatitis B	0.000301	0.0016	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.0003	0.0016	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000299	0.00159	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000294	0.00156	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—HNF4A—hepatitis B	0.000284	0.00151	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000274	0.00146	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000242	0.00129	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.000234	0.00124	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP2A6—hepatitis B	0.000208	0.00111	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000194	0.00103	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GOT2—hepatitis B	0.000188	0.001	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—ALB—hepatitis B	0.000184	0.00098	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—CTNNB1—hepatitis B	0.00017	0.000903	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—NFKB1—hepatitis B	0.000165	0.000876	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GOT1—hepatitis B	0.000162	0.000863	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GGT1—hepatitis B	0.000162	0.000863	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000148	0.000786	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TGFB1—hepatitis B	0.000137	0.00073	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000136	0.000723	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AKR1B1—hepatitis B	0.000134	0.00071	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TNF—hepatitis B	0.000128	0.000682	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GGT2—hepatitis B	0.000128	0.000681	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—IL6—hepatitis B	0.000103	0.00055	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AKR1B1—hepatitis B	8.81e-05	0.000469	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALB—hepatitis B	8.63e-05	0.000459	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GGT2—hepatitis B	8.45e-05	0.000449	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP2A6—hepatitis B	7.76e-05	0.000413	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	7.24e-05	0.000385	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GOT2—hepatitis B	7.02e-05	0.000373	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTEN—hepatitis B	6.59e-05	0.00035	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GGT1—hepatitis B	6.06e-05	0.000322	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GOT1—hepatitis B	6.06e-05	0.000322	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	5.52e-05	0.000294	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP2A6—hepatitis B	5.12e-05	0.000272	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GOT2—hepatitis B	4.63e-05	0.000246	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GOT1—hepatitis B	4e-05	0.000212	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GGT1—hepatitis B	4e-05	0.000212	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALB—hepatitis B	3.22e-05	0.000171	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTEN—hepatitis B	2.46e-05	0.000131	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALB—hepatitis B	2.13e-05	0.000113	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTEN—hepatitis B	1.62e-05	8.62e-05	CbGpPWpGaD
